Razor, inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Razor, inc - overview
Established
2015
Location
New York, NY, US
Primary Industry
Healthcare IT
About
Based in NY, US, and founded in 2015, Razor, inc trading as OccamzRazor develops machine learning methods to improve the success of Parkinson's disease drug discovery and development. In March 2022, Razor, inc raised USD 6. 1 million in venture funding led by an individual investor including Lauder Partners, re. Mind Capital, and Valor Equity Partners.
Katharina Sophia Volz (CEO) and Martin Bringmann (CSO) are the co-founders of the company. The company focuses on the discovery and development of modality agnostic treatments for complex diseases of brain aging. OccamzRazor’s platform identifies disease targets and mechanisms and it supercharges human scientific reasoning through machine learning. The firm develops the insight prediction pipeline that allows to automatically draw knowledge from millions of peer-reviewed publications, proprietary datasets, clinical trial findings, and own lab experiments.
The company partners with UAB, Axxam Neuroscience CRO, The Neuroscience Research Institute, and more. The organization plans to use the March 2022 funding to launch its discovery pipeline and advance preclinical development in Parkinson’s.
Current Investors
Valor Equity Partners, Lauder Partners, re.Mind Capital
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Pharmaceutical Research & Development
Website
www.occamzrazor.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.